Literature DB >> 2789919

The effect of a single oral dose of pergolide on intraocular pressure and pupil diameter.

M R al-Sereiti1, R F Quik, P Turner.   

Abstract

1. The ocular hypotensive effect of a single oral dose of 25 micrograms pergolide, a dopamine 2-receptor agonist, was studied in 12 normal human volunteers, using a non-invasive method. 2. An oral dose of timolol 20 mg was used as a positive control. 3. The effects of both drugs on pupil diameter were also studied, using a photographic method. 4. Considering the first 6 h post-dosing measurements, using multiple linear regression analysis comparing drug with placebo and including the baseline values as continuous independent variables, both pergolide and timolol had a significant ocular hypotensive effect in both eyes (P less than 0.0001) with no significant effects on pupil diameter. 5. Further topical application studies in normal and glaucomatous eyes are needed to evaluate the usefulness of pergolide in the treatment of glaucoma.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789919      PMCID: PMC1379943          DOI: 10.1111/j.1365-2125.1989.tb05425.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Effects of (8beta)-8-[methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in rats.

Authors:  R W Fuller; J A Clemens; E C Kornfeld; H D Snoddy; E B Smalstig; N J Bach
Journal:  Life Sci       Date:  1979-01-22       Impact factor: 5.037

2.  A new tonometer system.

Authors:  B Grolman
Journal:  Am J Optom Arch Am Acad Optom       Date:  1972-08

3.  The analysis of anisocoria. The use of photography in the clinical evaluation of unequal pupils.

Authors:  J S Czarnecki; S F Pilley; H S Thompson
Journal:  Can J Ophthalmol       Date:  1979-10       Impact factor: 1.882

4.  The pharmacological evaluation of pergolide mesylate as a potential anti-parkinson agent.

Authors:  W C Koller; W J Weiner; B I Diamond; P A Nausieda; H L Klawans
Journal:  Neuropharmacology       Date:  1980-09       Impact factor: 5.250

5.  [Does bromocriptine enhance the effect of drugs that reduce intraocular pressure?].

Authors:  A Lustig
Journal:  Dtsch Med Wochenschr       Date:  1983-10-28       Impact factor: 0.628

Review 6.  The non-contact tonometer. Its value and limitations.

Authors:  M B Shields
Journal:  Surv Ophthalmol       Date:  1980 Jan-Feb       Impact factor: 6.048

7.  Ocular hypotensive action of ergoline derivatives in rabbits: effects of sympathectomy and domperidone pretreatment.

Authors:  D E Potter; J A Burke; F W Chang
Journal:  Curr Eye Res       Date:  1984-02       Impact factor: 2.424

8.  Bromocriptine lowers intraocular pressure without affecting blood pressure.

Authors:  Q A Mekki; S M Hassan; P Turner
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

9.  Interaction of pergolide with central dopaminergic receptors.

Authors:  M Goldstein; A Lieberman; J Y Lew; T Asano; M R Rosenfeld; M H Makman
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more
  6 in total

1.  A comparison of the ocular hypotensive effect of 0.025% bromocriptine and 0.25% timolol eye drops in normal human volunteers.

Authors:  M R al-Sereiti; R L Coakes; D P O'Sullivan; P Turner
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

Review 2.  Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease.

Authors:  H D Langtry; S P Clissold
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

3.  Selective effects of low doses of apomorphine on spatiotemporal contrast sensitivity in healthy volunteers: a double-blind placebo-controlled study.

Authors:  O Blin; D Mestre; G Masson; G Serratrice
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

4.  Antagonism by domperidone of the ocular hypotensive effect of pergolide.

Authors:  M R al-Sereiti; R F Quik; A Hedges; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  A comparative study of topical natural ergot alkaloids on the intraocular pressure and aqueous humor dynamics in oclular normotensive and alpha-chymotrypsin-induced ocular hypertensive rabbits.

Authors:  Gustavo Puras; Juan Santafé; José Segarra; Manuel Garrido; José Melena
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-16       Impact factor: 3.117

Review 6.  Natural Ergot Alkaloids in Ocular Pharmacotherapy: Known Molecules for Novel Nanoparticle-Based Delivery Systems.

Authors:  Iara Baldim; Wanderley P Oliveira; Varsha Kadian; Rekha Rao; Nitesh Yadav; Sheefali Mahant; Massimo Lucarini; Alessandra Durazzo; Raquel Da Ana; Raffaele Capasso; Selma B Souto; Antonello Santini; Eliana B Souto
Journal:  Biomolecules       Date:  2020-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.